Peter J Kitonsa
Overview
Explore the profile of Peter J Kitonsa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kendall E, Kitonsa P, Nalutaaya A, Robsky K, Erisa K, Mukiibi J, et al.
Thorax
. 2023 Dec;
79(4):325-331.
PMID: 38050134
Background: Systematic screening is a potential tool for reducing the prevalence of tuberculosis (TB) and counteracting COVID-19-related disruptions in care. Repeated community-wide screening can also measure changes in the prevalence...
2.
Robsky K, Isooba D, Nakasolya O, Mukiibi J, Nalutaaya A, Kitonsa P, et al.
PLoS One
. 2021 May;
16(5):e0251806.
PMID: 33989343
Background: International and internal migration are recognized risk factors for tuberculosis (TB). Geographic mobility, including travel for work, education, or personal reasons, may also play a role in TB transmission,...
3.
Kitonsa P, Nalutaaya A, Mukiibi J, Nakasolya O, Isooba D, Kamoga C, et al.
PLoS One
. 2020 Dec;
15(12):e0243542.
PMID: 33306710
Background: When evaluating symptomatic patients for tuberculosis (TB) without access to same-day diagnostic test results, clinicians often make empiric decisions about starting treatment. The number of TB symptoms and/or underweight...
4.
Kendall E, Kitonsa P, Nalutaaya A, Erisa K, Mukiibi J, Nakasolya O, et al.
Clin Infect Dis
. 2020 Dec;
72(12):e1035-e1043.
PMID: 33283227
Background: New, sensitive diagnostic tests facilitate identification and investigation of milder forms of tuberculosis (TB) disease. We used community-based TB testing with the Xpert MTB/RIF Ultra assay ("Ultra") to characterize...
5.
Baik Y, Rickman H, Hanrahan C, Mmolawa L, Kitonsa P, Sewelana T, et al.
PLoS Med
. 2020 Nov;
17(11):e1003420.
PMID: 33170838
Background: In highly resource-limited settings, many clinics lack same-day microbiological testing for active tuberculosis (TB). In these contexts, risk of pretreatment loss to follow-up is high, and a simple, easy-to-use...
6.
Robsky K, Kitonsa P, Mukiibi J, Nakasolya O, Isooba D, Nalutaaya A, et al.
Infect Dis Poverty
. 2020 Jun;
9(1):73.
PMID: 32571435
Background: Routine tuberculosis (TB) notifications are geographically heterogeneous, but their utility in predicting the location of undiagnosed TB cases is unclear. We aimed to identify small-scale geographic areas with high...
7.
Kendall E, Kamoga C, Kitonsa P, Nalutaaya A, Salvatore P, Robsky K, et al.
PLoS One
. 2019 Jul;
14(7):e0220251.
PMID: 31339935
Background: Clinical tuberculosis diagnosis and empiric treatment have traditionally been common among patients with negative bacteriologic test results. Increasing availability of rapid molecular diagnostic tests, including Xpert MTB/RIF and the...